Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist
Alexandra Litvinchuk(Hope Center for Neurological Disorders), David M. Holtzman(Hope Center for Neurological Disorders), Melissa Manis(Hope Center for Neurological Disorders), Carla M. Yuede(Washington University in St. Louis), Anil G. Cashikar(Boston Biomedical Research Institute), Enmanuel J. Perez(Hope Center for Neurological Disorders), Eric Tycksen(Washington University in St. Louis), Sonnet S. Davis(Denali Therapeutics (United States)), Nga Bien‐Ly(Toxicologie, Pharmacologie et Signalisation Cellulaire), Jason D. Ulrich(Hope Center for Neurological Disorders), Javier Remolina Serrano(Hope Center for Neurological Disorders), Gilbert Di Paolo(Columbia University Irving Medical Center), G. Travis Tabor(Hope Center for Neurological Disorders), Jing Guo(Singapore Bioimaging Consortium), Xin Bao(Weihai Maternal and Child Health Hospital), Karin Lin(Denali Therapeutics (United States)), Choonghee Lee(Hope Center for Neurological Disorders), Jung H. Suh(Denali Therapeutics (United States)), Megan E. Bosch(Washington University in St. Louis)
Cited by 18
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
|Nature Neuroscience|2002|858
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
|Cold Spring Harbor Perspectives in Medicine|2012|787